Board of Directors

Marty Tenenbaum is a renowned computer scientist, Internet entrepreneur and cancer survivor. He founded Cancer Commons and CollabRx (NASD: CRLX) to help each cancer patient obtain the best possible outcome. He is an Internet commerce pioneer and visionary, having founded EIT (1990) and CommerceNet (1994) to accelerate business use of the Internet, and later, was an officer and director of Commerce One, Webify Solutions (sold to IBM in 2006), and Medstory (sold to Microsoft in 2007). Dr. Tenenbaum is a fellow and former board member of the American Association for Artificial Intelligence, and a former Director of Patients Like Me. Dr. Tenenbaum holds BS and MS degrees in Electrical Engineering from MIT, and a PhD from Stanford, and has received numerous awards for his work in AI and as a patient advocate.

Mika has more than 20 years of commercial strategy and leadership experience in life sciences, with a focus on novel technologies. Over the last 10 years Mika has concentrated on evidence-based medicine and tools to transform healthcare and clinical development.

Before joining xCures Mika was the Chief Commercial Officer of Doctor Evidence, LLC. Prior to Doctor Evidence he was the General Manager of Clinical Development Services at diaDexus, SVP of Client and Market Development at Evidera, VP of Sales and Marketing at Archimedes, and held sales management and sales operations roles at Quintiles, Invitrogen and Tripos.

Moe Kermani is a Managing Partner of Vanedge Capital where he focuses on investments in Cloud computing, Artificial Intelligence, Cybersecurity, Analytics, and Quantum Information. Prior to that he was President and CEO of Bycast Inc., a world leader in object storage that was successfully acquired by NetApp. Moe has extensive experience working with entrepreneurial companies and taking to market leading-edge technology products. He holds PhD in physics from the University of British Columbia.b